| Title |
Critical review of the responsive neurostimulator system for epilepsy
|
|---|---|
| Published in |
Medical Devices : Evidence and Research, October 2015
|
| DOI | 10.2147/mder.s62853 |
| Pubmed ID | |
| Authors |
George P Thomas, Barbara C Jobst |
| Abstract |
Patients with medically refractory epilepsy have historically had few effective treatment options. Electrical brain stimulation for seizures has been studied for decades and ongoing technological refinements have made possible the development of an implantable electrical brain stimulator. The NeuroPace responsive neurostimulator was recently approved by the FDA for clinical use and the initial reports are encouraging. This device continually monitors brain activity and delivers an electric stimulus when abnormal activity is detected. Early reports of efficacy suggest that the device is well tolerated and offers a reduction in seizure frequency by approximately half at 2 years. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 191 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 191 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 39 | 20% |
| Student > Bachelor | 28 | 15% |
| Researcher | 20 | 10% |
| Student > Master | 18 | 9% |
| Student > Doctoral Student | 15 | 8% |
| Other | 32 | 17% |
| Unknown | 39 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Engineering | 47 | 25% |
| Medicine and Dentistry | 35 | 18% |
| Neuroscience | 23 | 12% |
| Agricultural and Biological Sciences | 10 | 5% |
| Biochemistry, Genetics and Molecular Biology | 6 | 3% |
| Other | 23 | 12% |
| Unknown | 47 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2022.
All research outputs
#1,780,737
of 25,584,565 outputs
Outputs from Medical Devices : Evidence and Research
#24
of 303 outputs
Outputs of similar age
#24,324
of 287,342 outputs
Outputs of similar age from Medical Devices : Evidence and Research
#2
of 11 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 303 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.7. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,342 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.